Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Deloitte
Daiichi Sankyo
Harvard Business School
Moodys
Chubb
Cerilliant
Colorcon
QuintilesIMS

Generated: October 17, 2018

DrugPatentWatch Database Preview

Delcor Asset Corp Company Profile

« Back to Dashboard

What is the competitive landscape for DELCOR ASSET CORP, and what generic and branded alternatives to DELCOR ASSET CORP drugs are available?

DELCOR ASSET CORP has seventeen approved drugs.



Summary for Delcor Asset Corp

Drugs and US Patents for Delcor Asset Corp

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp MYCOSTATIN nystatin POWDER;TOPICAL 060578-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Delcor Asset Corp MYCOLOG-II nystatin; triamcinolone acetonide CREAM;TOPICAL 060576-002 May 1, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Delcor Asset Corp KENACORT triamcinolone TABLET;ORAL 011283-010 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Delcor Asset Corp KENALOG-H triamcinolone acetonide CREAM;TOPICAL 086240-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Delcor Asset Corp MYCOSTATIN nystatin TABLET;VAGINAL 060577-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Delcor Asset Corp PHENERGAN promethazine hydrochloride TABLET;ORAL 007935-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Covington
Chubb
Moodys
Daiichi Sankyo
Baxter
Healthtrust
Medtronic
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.